S.F. genetic company will retest 50,000 saliva samples after error creates false negatives for cancer gene

A San Francisco-based genetic diagnostics company will retest 50,000 saliva samples after a genetic counselor noticed that it had created a false negative for a genetic marker that can be linked to hereditary colon cancer, the company said this week. Invitae Corp. (NYSE: NVTA) said after being notified of the error, it will now retest thousands of samples, and has thus far found two patients who had the wrong results. A spokesperson told the Business Times that the company doesn't expect more than…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news